# The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure

> **NCT00043836** · PHASE2 · COMPLETED · sponsor: **Synvista Therapeutics, Inc** · enrollment: 20 (—)

## Conditions studied

- Heart Failure, Congestive
- Dyspnea
- Pulmonary Edema

## Interventions

- **DRUG:** ALT-711

## Key facts

- **NCT ID:** NCT00043836
- **Lead sponsor:** Synvista Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2003-02
- **Final completion:** 2005-10
- **Target enrollment:** 20 (—)
- **Last updated:** 2009-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043836, "The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00043836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*